Press release
Dentsply Sirona Reports Fourth Quarter and Full Year 2021 Results
FY21 net sales increased 27.2% to $4,251 million, organic sales increased 24.6%FY21 operating income of $622 million, adjusted operating income increased
About this update from Dentsply Sirona Inc.
[{"type":"text","content":"FY21 net sales increased 27.2% to $4,251 million, organic sales increased 24.6%FY21 operating income of $622 million, adjusted operating income increased 62.3% to $871 million FY21 EPS of $1.91, adjusted EPS increased 60.3% to $2.87FY21 operating cash flow increased to $657 million vs $635 million in FY20Q4 net sales increased 0.6% to $1,088 million, organic sales increased 1.8%Q4 operating income of $154 million, adjusted operating income decreased 13.7% to $217 million FY22 outlook: organic sales growth 4% to 5%, adjusted EPS range of $3.05 to $3.25 CHARLOTTE, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the \"Company\") (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year 2021. Full year 2021 net sales of $4,251 million increased 27.2%, compared to $3,342 million for the full year of 2020. Net income was $421 million, or $1.91 per diluted share, compared to a loss of ($83) million, or ($0.38) per diluted share for the full year of 2020. Adjusted earnings per diluted share grew to $2.87 compared to $1.79 in 2020. Adjusted EBITDA for the full year of 2021 was $992 million, compared to $666 million in 2020. A reconciliation of Non-GAAP measures (including organic sales, adjusted operating income and margin, adjusted EPS, and adjusted EBITDA) to GAAP measures is provided below. Fourth quarter 2021 net sales of $1,088 million increased 0.6%, compared to $1,082 million in the fourth quarter of 2020. Net income was $102 million, or $0.47 per diluted share, compared to $99 million, or $0.45 per diluted share in the fourth quarter of 2020. Adjusted earnings per diluted share decreased to $0.76 compared to $0.87 in the fourth quarter of 2020. “Our 2021 performance reflects the resilience of the dental market, the strength of our global portfolio, and our team's ability to execute well in an environment still impacted by the pandemic. We delivered strong results with organic sales growth of nearly 25%, double-digit EPS growth, and solid cash flow generation. We made meaningful progress on the commitments we set three years ago to strengthen the foundation of the business and position it for long-term sustainable growth,\" said Don Casey, Chief Executive Officer. \"We are optimistic about our future. We have a healthy innovation pipeline, a well-positioned portfol...